Cargando…

ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women

African American woman are 43% more likely to die from breast cancer than white women and have increased the risk of tumor recurrence despite lower incidence. We investigate variations in microsatellite genomic regions—a type of repetitive DNA—and possible links to the breast cancer mortality gap. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinney, Nick, Varghese, Robin T, Anandakrishnan, Ramu, Garner, Harold R “Skip”
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734450/
https://www.ncbi.nlm.nih.gov/pubmed/29276372
http://dx.doi.org/10.1177/1176935117746644
_version_ 1783287060144062464
author Kinney, Nick
Varghese, Robin T
Anandakrishnan, Ramu
Garner, Harold R “Skip”
author_facet Kinney, Nick
Varghese, Robin T
Anandakrishnan, Ramu
Garner, Harold R “Skip”
author_sort Kinney, Nick
collection PubMed
description African American woman are 43% more likely to die from breast cancer than white women and have increased the risk of tumor recurrence despite lower incidence. We investigate variations in microsatellite genomic regions—a type of repetitive DNA—and possible links to the breast cancer mortality gap. We screen 33 854 microsatellites in germline DNA of African American women with and without breast cancer: 4 are statistically significant. These are located in the 3′ UTR (untranslated region) of gene ZDHHC3, an intron of transcribed pseudogene INTS4L1, an intron of ribosomal gene RNA5-8S5, and an intergenic region of chromosome 16. The marker in ZDHHC3 is interesting for 3 reasons: (a) the ZDHHC3 gene is located in region 3p21 which has already been linked to early invasive breast cancer, (b) the Kaplan-Meier estimator demonstrates that ZDHHC3 alterations are associated with poor breast cancer survival in all racial/ethnic groups combined, and (c) data from cBioPortal suggest that ZDHHC3 messenger RNA expression is significantly lower in African Americans compared with whites. These independent lines of evidence make ZDHHC3 a candidate for further investigation.
format Online
Article
Text
id pubmed-5734450
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57344502017-12-22 ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women Kinney, Nick Varghese, Robin T Anandakrishnan, Ramu Garner, Harold R “Skip” Cancer Inform Original Research African American woman are 43% more likely to die from breast cancer than white women and have increased the risk of tumor recurrence despite lower incidence. We investigate variations in microsatellite genomic regions—a type of repetitive DNA—and possible links to the breast cancer mortality gap. We screen 33 854 microsatellites in germline DNA of African American women with and without breast cancer: 4 are statistically significant. These are located in the 3′ UTR (untranslated region) of gene ZDHHC3, an intron of transcribed pseudogene INTS4L1, an intron of ribosomal gene RNA5-8S5, and an intergenic region of chromosome 16. The marker in ZDHHC3 is interesting for 3 reasons: (a) the ZDHHC3 gene is located in region 3p21 which has already been linked to early invasive breast cancer, (b) the Kaplan-Meier estimator demonstrates that ZDHHC3 alterations are associated with poor breast cancer survival in all racial/ethnic groups combined, and (c) data from cBioPortal suggest that ZDHHC3 messenger RNA expression is significantly lower in African Americans compared with whites. These independent lines of evidence make ZDHHC3 a candidate for further investigation. SAGE Publications 2017-12-13 /pmc/articles/PMC5734450/ /pubmed/29276372 http://dx.doi.org/10.1177/1176935117746644 Text en © The Author(s) 2017 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Kinney, Nick
Varghese, Robin T
Anandakrishnan, Ramu
Garner, Harold R “Skip”
ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title_full ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title_fullStr ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title_full_unstemmed ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title_short ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
title_sort zdhhc3 as a risk and mortality marker for breast cancer in african american women
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734450/
https://www.ncbi.nlm.nih.gov/pubmed/29276372
http://dx.doi.org/10.1177/1176935117746644
work_keys_str_mv AT kinneynick zdhhc3asariskandmortalitymarkerforbreastcancerinafricanamericanwomen
AT vargheserobint zdhhc3asariskandmortalitymarkerforbreastcancerinafricanamericanwomen
AT anandakrishnanramu zdhhc3asariskandmortalitymarkerforbreastcancerinafricanamericanwomen
AT garnerharoldrskip zdhhc3asariskandmortalitymarkerforbreastcancerinafricanamericanwomen